Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Singhal Priya
Biogen | 144: Notice of proposed sale of securities pursuant to Rule 144
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer ALEXANDER SUSAN H
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Gregory Ginger
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Izzar Rachid
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Kramer Robin
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer MCDONNELL MICHAEL R
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Murphy Nicole
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Singhal Priya
Biogen | 144: Notice of proposed sale of securities pursuant to Rule 144
Biogen | 4: Statement of changes in beneficial ownership of securities-Director Rowinsky Eric K
Biogen | 10-K: Annual report
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Gregory Ginger
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Singhal Priya
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer MCDONNELL MICHAEL R
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Murphy Nicole
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Kramer Robin
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Izzar Rachid
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer ALEXANDER SUSAN H
Biogen | 8-K: Biogen reports fourth quarter and full year 2023 results and expects return to Non-GAAP EPS growth in 2024
No Data